Patent Yard Sign in
Canadian application, no grantCanada

N-(3,5-dichloro-2-methoxyphenyl)-4-methoxy-3-piperazin-1-yl-benzenesulfonamide

CA 2420935 A1 · Owner: Bromidge, Steven Mark · Inventors: Bromidge, Steven Mark; Moss, Stephen Frederick

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The invention relates to a novel sulfonamide compound having pharmacological activity, a process for its preparation to compositions containing the same , and to its use in the treatment of various disorders particularly CNS , disorders.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed August 27, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 27, 2021.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 27, 2023.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledAugust 27, 2001
GrantedNo grant recorded
Term endedAugust 27, 2021
Patent numberCA 2420935 A1
Classification (IPC)C07D295/09 +2 more

Timeline

Timeline From CIPO dates

2002200420062008201020122014201620182020Application filedAug 27, 2001Term endedAug 27, 2021

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.